StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)

Close on Nov 13, 2026Market cap $342.73MP/E –Yield –

Treace Medical Concepts statistics

83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 26, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$342.73M
$498.53M
Enterprise Value
$362.98M
$433.11M
PS Ratio
1.69
2.94
PB Ratio
5.56
3.24
P/TBV Ratio
8.08
4.81

Enterprise valuationIndustry

EV / Sales
1.79
2.60

Share statisticsIndustry

Shares Change (YoY)
2.96%
3.32%
Float
47M
37M
Shares Held by Insiders
28.0%
10.5%
Shares Held by Institutions
49.0%
60.5%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
-6.91%
-2.57%
Short % of Float
3.82%
5.11%
Short % of Shares Outstanding
2.75%
3.98%
Days to Cover
8.65
3.94

Stock price statisticsIndustry

52-Week High
$5.44
–
52-Week Low
$1.17
–
20-Day Moving Average
$4.53
–
50-Day Moving Average
$4.43
–
200-Day Moving Average
$3.34
–
Average True Range (14)
$0.44
–
Price Change (1 Week)
30.8%
0.99%
Price Change (1 Month)
27.9%
-3.52%
Price Change (3 Months)
17.1%
-7.86%
Price Change (6 Months)
98.1%
-1.12%
Price Change (YTD)
115.1%
-2.92%
Price Change (1 Year)
58.5%
-1.37%
Price Change (3 Years)
-27.7%
3.24%
Price Change (5 Years)
-75.8%
-50.4%
Average Volume (10 Days)
442,485
–
Average Volume (20 Days)
329,935
–
Average Volume (90 Days)
316,847
–
Relative Volume
0.90
0.76
Relative Strength Index (14)
63.9
46.7
Volatility (1 Year)
83.9%
64.2%
Beta (5 Years)
1.70
1.04

MarginsIndustry

Gross Margin
79.6%
55.9%
Operating Margin
-24.4%
-5.12%
Profit Margin
-27.4%
-9.29%
EBITDA Margin
-20.6%
-2.52%
FCF Margin
-9.13%
0.65%

Returns on capitalIndustry

Return on Equity (ROE)
-74.0%
-17.3%
Return on Assets (ROA)
-29.7%
-12.3%
Return on Invested Capital (ROIC)
-46.4%
-2.83%
Return on Capital Employed (ROCE)
-37.2%
-8.13%

Financial positionIndustry

Current Ratio
2.58
2.49
Quick Ratio
1.52
1.53
Debt / Equity
0.97
0.42
Interest Coverage
-8.17
-1.63

GrowthIndustry

Revenue Growth (YoY)
-7.10%
9.42%
Revenue Growth (3Y CAGR)
14.5%
7.08%
Revenue Growth (5Y CAGR)
30.0%
11.8%

EfficiencyIndustry

Asset Turnover
1.08
0.59
Inventory Turnover
0.99
2.20
Revenue Per Employee
$451.88K
$331.99K
Profits Per Employee
-$123.99K
-$46.47K
Employee Count
450
193
WACC
12.8%
9.91%

Income statement (TTM)Industry

Revenue
$203.35M
$108.17M
Gross Profit
$161.77M
$62.29M
Operating Income
-$49.58M
-$3.72M
Net Income
-$55.79M
-$6.19M
EBITDA
-$41.95M
-$1.98M
EPS (Diluted)
-$0.86
-$0.11

Balance sheetIndustry

Total Debt
$60.05M
$96.00M
Net Cash (Debt)
-$20.25M
$3.95M
Net Cash Per Share
-$0.31
$0.26
Equity (Book Value)
$61.65M
$63.80M
Book Value Per Share
$0.95
$3.26
Tangible Book Value
$42.42M
$11.61M
Working Capital
$72.61M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.74M
-$483.87K
Capital Expenditures
-$9.83M
-$3.94M
Free Cash Flow
-$18.57M
-$238.00K
FCF Per Share
-$0.29
-$0.00

Dividends and yieldsIndustry

Earnings Yield
-16.3%
-4.76%
FCF Yield
-5.42%
0.28%

Taxes and interestIndustry

Interest Expense
$6.07M
$5.40M

Scores and fair valueIndustry

Altman Z-Score
0.15
2.47
Piotroski F-Score
2
5
Beneish M-Score
-3.50
-2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodTMCIS&P 500DifferenceTMCI per yearS&P 500 per year
1 month+28.5%-3.0%+31.6 pts
3 months+16.9%-2.8%+19.6 pts
Year to date+115.1%+11.5%+103.6 pts
1 year+67.8%+13.5%+54.4 pts
3 years-12.6%+77.7%−90.3 pts-4.4%+21.1%
5 years-75.8%+72.6%−148.4 pts-24.7%+11.5%
10 years+78.6%+308.2%−229.5 pts+6.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M TMCI shares were sold short on Oct 30, 2026, down 6.9% from the previous report, or 3.82% of the shares available to trade. At recent volumes it would take 8.7 days to buy them back. Over the last 20 sessions, 26.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,791,040-6.9%206,9518.7
Oct 15, 20261,924,027-2.7%230,7868.3
Sep 30, 20261,976,907+13.8%229,9428.6
Sep 15, 20261,736,595+11.3%205,2558.5
Aug 31, 20261,560,809-2.2%291,7755.3
Aug 14, 20261,596,168-6.1%537,5313.0
Jul 31, 20261,699,587-7.9%310,9245.5
Jul 15, 20261,844,752+5.5%515,1773.6
Jun 30, 20261,748,502-46.6%1,687,9611.0
Jun 15, 20263,271,388-20.4%721,9514.5
May 29, 20264,108,513+13.7%559,9337.3
May 15, 20263,613,472-8.8%581,6886.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?